Name: Initial public offering of Genticel on Euronext Paris
Uploaded: 2014-04-04T09:58:15+0200
Description: Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris. Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.

Søk Kontakt

Denne siden er tilgjengelig på flere språk

Select Language

Back

04/04/2014

Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris.

Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.